PRIVIA HEALTH GROUP INC (PRVA) Stock Fundamental Analysis

NASDAQ:PRVA • US74276R1023

21.83 USD
+0.05 (+0.23%)
At close: Feb 19, 2026
21.83 USD
0 (0%)
After Hours: 2/19/2026, 8:26:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 102 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PRVA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • PRVA had positive earnings in the past year.
  • In the past year PRVA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
  • In the past 5 years PRVA always reported a positive cash flow from operatings.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • PRVA has a Return On Assets of 1.34%. This is comparable to the rest of the industry: PRVA outperforms 51.96% of its industry peers.
  • With a Return On Equity value of 2.56%, PRVA perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
  • PRVA's Return On Invested Capital of 2.45% is in line compared to the rest of the industry. PRVA outperforms 46.08% of its industry peers.
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROIC 2.45%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • With a Profit Margin value of 0.89%, PRVA perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PRVA has declined.
  • The Operating Margin of PRVA (1.38%) is comparable to the rest of the industry.
  • PRVA's Operating Margin has declined in the last couple of years.
  • PRVA has a worse Gross Margin (10.17%) than 74.51% of its industry peers.
  • PRVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
  • PRVA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PRVA has been increased compared to 5 years ago.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.26 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA has a better Altman-Z score (4.26) than 77.45% of its industry peers.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.26
ROIC/WACC0.28
WACC8.73%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.67, PRVA is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
  • PRVA has a Quick Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of PRVA (1.67) is better than 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
  • PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
  • The Revenue has grown by 19.01% in the past year. This is quite good.
  • The Revenue has been growing by 17.17% on average over the past years. This is quite good.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%

3.2 Future

  • Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 59.93% on average per year.
  • Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.73% on average per year.
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • PRVA is valuated quite expensively with a Price/Earnings ratio of 167.92.
  • Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.09. PRVA is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 67.82, PRVA can be considered very expensive at the moment.
  • PRVA's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (27.98), we can say PRVA is valued expensively.
Industry RankSector Rank
PE 167.92
Fwd PE 67.82
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • PRVA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRVA is more expensive than 61.76% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PRVA.
Industry RankSector Rank
P/FCF 24.26
EV/EBITDA 60.01
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as PRVA's earnings are expected to grow with 59.93% in the coming years.
PEG (NY)7.63
PEG (5Y)22.59
EPS Next 2Y71.06%
EPS Next 3Y59.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PRVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (2/19/2026, 8:26:24 PM)

After market: 21.83 0 (0%)

21.83

+0.05 (+0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners98.68%
Inst Owner Change-0.92%
Ins Owners1.85%
Ins Owner Change0%
Market Cap2.69B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.29
Price Target32.15 (47.27%)
Short Float %2.31%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.08%
PT rev (3m)-0.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.01%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)-4.09%
Revenue NQ rev (3m)-29.23%
Revenue NY rev (1m)-39.88%
Revenue NY rev (3m)-37.44%
Valuation
Industry RankSector Rank
PE 167.92
Fwd PE 67.82
P/S 1.31
P/FCF 24.26
P/OCF 24.26
P/B 3.79
P/tB 7.27
EV/EBITDA 60.01
EPS(TTM)0.13
EY0.6%
EPS(NY)0.32
Fwd EY1.47%
FCF(TTM)0.9
FCFY4.12%
OCF(TTM)0.9
OCFY4.12%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)7.63
PEG (5Y)22.59
Graham Number4.11
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 2.56%
ROCE 3.67%
ROIC 2.45%
ROICexc 5.77%
ROICexgc N/A
OM 1.38%
PM (TTM) 0.89%
GM 10.17%
FCFM 5.42%
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 112.37
Cash Conversion 296.89%
Profit Quality 609.36%
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z 4.26
F-Score7
WACC8.73%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y71.06%
EPS Next 3Y59.93%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year-27.71%
Revenue Next 2Y-9.42%
Revenue Next 3Y-3.6%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.42%
EBIT Next 3Y111.21%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%

PRIVIA HEALTH GROUP INC / PRVA FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 167.92 and the Price/Book (PB) ratio is 3.79.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.